Top
OR2AK2 has not been detected as a mutational cancer driver

OR2AK2
Ensembl id ENSG00000187080
Mutated samples
Coding Sequence 63 (0.9%)
Protein Affecting 49 (0.7%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all OR2AK2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Lung adenocarcinoma No 15 11 2.81
Cutaneous melanoma No 15 10 2.71
Lung squamous cell carcinoma No 8 7 4.02
Head and neck squamous cell carcinoma No 5 5 1.33
Stomach adenocarcinoma No 4 4 2.48
Esophageal carcinoma No 3 3 2.05
Breast carcinoma No 3 2 0.17
Small cell lung carcinoma No 2 2 2.90
Medulloblastoma No 1 1 0.48
Uterine corpus endometrioid carcinoma No 1 1 0.43
Non small cell lung carcinoma No 1 1 3.23
Serous ovarian adenocarcinoma No 1 1 0.32
Glioblastoma multiforme No 2 1 0.26
Bladder carcinoma No 1 0 0.00
Chronic lymphocytic leukemia No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence